<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>UNLABELLED: Few diagnostic procedures are available to determine the degree of bone marrow cellularity and the numbers of cycling cells in patients with <z:e sem="disease" ids="C0005956" disease_type="Disease or Syndrome" abbrv="">bone marrow disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Noninvasive imaging of the bone marrow compartment may be helpful </plain></SENT>
<SENT sid="2" pm="."><plain>The PET tracer 3'-fluoro-3'-deoxy-L-<z:chebi fb="0" ids="17748">thymidine</z:chebi> (<z:chebi fb="0" ids="36939">18F</z:chebi>-FLT) has been developed recently </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="36939">18F</z:chebi>-FLT uptake is related to the rate of DNA synthesis and increases with higher proliferation rates in many types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Background uptake of <z:chebi fb="0" ids="36939">18F</z:chebi>-FLT in bone marrow is common </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="36939">18F</z:chebi>-FLT PET might, therefore, visualize the high cycling activity of hematopoietic cells in the bone marrow compartment </plain></SENT>
<SENT sid="6" pm="."><plain>Therefore, we investigated the feasibility of visualization and quantification of the activity of the bone marrow compartment with <z:chebi fb="0" ids="36939">18F</z:chebi>-FLT PET to distinguish different <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorders</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>METHODS: Clinical and laboratory data of 18 patients with <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo>, <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo>, <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, or <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> were correlated with the results of <z:chebi fb="0" ids="36939">18F</z:chebi>-FLT PET using visual analysis and the standardized uptake value (SUV) </plain></SENT>
<SENT sid="8" pm="."><plain>Findings were compared with those of healthy control subjects (n = 14) </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: With SUV and visual analysis, a distinction could be made between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (n = 9), <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> (n = 3), and <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> (n = 3) compared with healthy control subjects </plain></SENT>
<SENT sid="10" pm="."><plain>A significant increase in <z:chebi fb="0" ids="36939">18F</z:chebi>-FLT uptake was observed in <z:hpo ids='HP_0000001'>all</z:hpo> of the studied patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>In contrast, patients with <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (n = 1) demonstrated a decline in bone marrow <z:chebi fb="0" ids="36939">18F</z:chebi>-FLT uptake compared with healthy control subjects </plain></SENT>
<SENT sid="12" pm="."><plain>Comparable results were observed in osteolytic lesions of patients with <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> (n = 2) </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSION: <z:chebi fb="0" ids="36939">18F</z:chebi>-FLT PET can be used to visualize the proliferative activity of the bone marrow compartment and may be helpful to distinguish separate <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorders</z:e> </plain></SENT>
</text></document>